DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo

Celgene (NASDAQ: CELG)

114.93 -1.09 (-0.94%)

REAL-TIME: Last trade at

Extended Hours: $114.81 -$0.12 (-0.10%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $114.93 -0.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.84
Previous Close $116.02
Daily Range $114.35 - $116.23
52-Week Range $75.62 - $129.06
Market Cap $91.2B
P/E Ratio 39.73
Dividend (Yield) $0.00 (0.0%)
Volume 2,811,542
Average Daily Volume 4,977,097
Current FY EPS $4.11




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

Undervalued Stocks in Biotech Worth Buying

Even though the term "bubble" is being tossed around with regard to biotech stocks, there are still three undervalued stocks in the sector worth buying.

BMO: Celgene Still A Buy On This 'Important Future Driver'

As Cancer Immunotherapy Turns 125, WBB Securities' Steve Brozak Ponders What Investors Can Expect Fr

As Cancer Immunotherapy Turns 125, WBB Securities' Steve Brozak Ponders What Investors Can Expect From Biotech Next

Celladon's Failure Shouldn't Trickle Down To Other Gene Therapy Biotechs

Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

Pop! 3 To Buy If Biotech Stocks Burst

Biotech stocks are falling slightly from their lofty levels, and that may create some interesting opportunities to buy.

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

3 Stock Market Tips for the Biotech Industry

When it comes to biotech investing, think differently.

Large Companies With Fastest Revenue and Earnings Growth in 2015

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

See More CELG News...

CELG's Top Competitors

CELG $114.93 (-0.94%)
Current stock: CELG
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
$0.00 (0.00%)
Current stock: